IEEPA Tariff Refund Recovery
India is a major U.S. import source for pharmaceuticals, textiles, and IT equipment. IEEPA tariffs on Indian goods created recoverable duty obligations for U.S. importers.
India is among the top ten U.S. import source countries, with particular strength in pharmaceutical ingredients and generics, textile and apparel products, IT hardware and software-embedded devices, and gems and jewelry. IEEPA tariffs applied to select categories of Indian goods, generating duty collections that are now subject to the federal court refund order.
India supplies a significant share of U.S. generic drug API imports. IEEPA duties on pharmaceutical ingredients represent a critical supply chain cost that is now partially recoverable.
Indian cotton textiles, technical fabrics, and ready-made garments — assess IEEPA exposure across HTS chapters 50–63.
Diamonds, gemstones, and finished jewelry processed in India. High per-unit values with potential for significant per-entry IEEPA duty recovery.
Many Indian goods have historically received Generalized System of Preferences (GSP) duty-free treatment. However, where IEEPA duties were imposed as an additional layer on GSP-eligible goods — or where GSP benefits were suspended — separate IEEPA duty payments may have accumulated. TariffIQ™ analyzes the full duty history for India-origin entries to identify all recoverable amounts.
U.S. importers paid billions in IEEPA tariffs that a federal court has ordered refunded. Time-sensitive — act before CBP processing windows close.
Free Assessment Start Claim